Nitropress (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the Nitropress drug offered from Valeant Pharmaceuticals North America LLC. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: sodium nitroprusside
SUBSTANCE NAME: SODIUM NITROPRUSSIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vasodilation [PE],Vasodilator [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-12-01
END MARKETING DATE: 0000-00-00


Nitropress HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNitropress from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/2mL)
START MARKETING DATE: 2013-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-4302_fd76b793-d446-4d22-b905-aa981c0b5bf3
PRODUCT NDC: 0187-4302
APPLICATION NUMBER: ANDA071961

Other SODIUM NITROPRUSSIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Sodium Nitroprusside
EXELA PHARMA SCIENCES, LLCNIPRIDE RTU
Nexus Pharmaceuticals IncSodium Nitroprusside
Sagent PharmaceuticalsSodium Nitroprusside
Valeant Pharmaceuticals North America LLCNitropress